{
    "organizations": [],
    "uuid": "ba94b8212545ec5998b1861179b1bf55d0c6da21",
    "author": "cnbc.com",
    "url": "http://www.cnbc.com/2018/05/10/pr-newswire-gbt-reports-first-quarter-2018-results.html",
    "ord_in_thread": 0,
    "title": "GBT Reports First Quarter 2018 Results",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "MONTEVIDEO, Uruguay, Biotoscana Investments S.A. (B3: GBIO33), a biopharmaceutical group that operates in Latin America, announced today its results for the 1Q18.\nHIGHLIGHTS\nGross revenues for 1Q18 grew 10% in constant currency, marking BRL 927M LTM.\nNet revenues for 1Q18 increased by 9% in constant currency, marking BRL820M LTM. 1Q18 grew 12% pro-forma in constant currency (including bids for which we got a purchase order in 1Q18 but we expect to delivery in 2Q18).\nGross profit up 18% in 1Q18, in constant currency. Gross margin of 56% (up ~351bps from 1Q17), continuing the improvement trend of prior quarters.\nAdjusted EBITDA increased by 20% in constant currency vs. 1Q17. Adjusted EBITDA margin came to 25% in 1Q18, improving 172bps vs. 1Q17, marking BRL 203M LTM compared to BRL187M in 1Q17 LTM.\nAdjusted net income up 41% from 1Q17, reaching BRL 22M in 1Q18.\nHalaven and Abraxane off to a strong start. Lenvima launching ahead of schedule and improving clinical profile. Cresemba attained orphan status in Brazil and Mexico.\nExtended partnership with Gilead into the Andean region , with revenues starting in 2Q18.\nContacts:\nMelissa Angelini\nir@grupobiotoscana.com\n+55-11-5090-5927\n releases/gbt-reports-first-quarter-2018-results-300646819.html\nSOURCE Grupo Biotoscana",
    "published": "2018-05-11T02:54:00.000+03:00",
    "crawled": "2018-05-11T04:29:53.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "montevideo",
        "uruguay",
        "biotoscana",
        "investment",
        "b3",
        "gbio33",
        "biopharmaceutical",
        "group",
        "operates",
        "latin",
        "america",
        "announced",
        "today",
        "result",
        "1q18",
        "highlight",
        "gross",
        "revenue",
        "1q18",
        "grew",
        "constant",
        "currency",
        "marking",
        "brl",
        "927m",
        "ltm",
        "net",
        "revenue",
        "1q18",
        "increased",
        "constant",
        "currency",
        "marking",
        "brl820m",
        "ltm",
        "1q18",
        "grew",
        "constant",
        "currency",
        "including",
        "bid",
        "got",
        "purchase",
        "order",
        "1q18",
        "expect",
        "delivery",
        "2q18",
        "gross",
        "profit",
        "1q18",
        "constant",
        "currency",
        "gross",
        "margin",
        "1q17",
        "continuing",
        "improvement",
        "trend",
        "prior",
        "quarter",
        "adjusted",
        "ebitda",
        "increased",
        "constant",
        "currency",
        "1q17",
        "adjusted",
        "ebitda",
        "margin",
        "came",
        "1q18",
        "improving",
        "172bps",
        "1q17",
        "marking",
        "brl",
        "203m",
        "ltm",
        "compared",
        "brl187m",
        "1q17",
        "ltm",
        "adjusted",
        "net",
        "income",
        "1q17",
        "reaching",
        "brl",
        "22m",
        "1q18",
        "halaven",
        "abraxane",
        "strong",
        "start",
        "lenvima",
        "launching",
        "ahead",
        "schedule",
        "improving",
        "clinical",
        "profile",
        "cresemba",
        "attained",
        "orphan",
        "status",
        "brazil",
        "mexico",
        "extended",
        "partnership",
        "gilead",
        "andean",
        "region",
        "revenue",
        "starting",
        "2q18",
        "contact",
        "melissa",
        "angelini",
        "ir",
        "source",
        "grupo",
        "biotoscana"
    ]
}